Cargando…

Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II

BACKGROUND: Trypanosoma cruzi is the etiological agent of Chagas disease (CD) or American trypanosomiasis, an important public health problem in Latin America. Benznidazole (BZ), a drug available for its treatment, has limited efficacy and significant side effects. Essential oils (EOs) have demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarto, Marcella Paula Mansano, Lucas da Silva, Hevillyn Fernanda, de Souza Fernandes, Nilma, de Abreu, Ana Paula, Zanusso Junior, Gerson, de Ornelas Toledo, Max Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908772/ https://www.ncbi.nlm.nih.gov/pubmed/33632196 http://dx.doi.org/10.1186/s12906-021-03248-8

Ejemplares similares

Infection susceptibility and vector competence of Rhodnius robustus Larrousse, 1927 and R. pictipes Stal, 1872 (Hemiptera, Reduviidae, Triatominae) for strains of Trypanosoma cruzi (Chagas, 1909) (Kinetoplastida, Trypanosomatidae) I, II and IV
por: de Abreu, Ana Paula, et al.
Publicado: (2022)

Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
por: Fonseca, Kátia da Silva, et al.
Publicado: (2021)

Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
por: Trochine, Andrea, et al.
Publicado: (2014)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011)

Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
por: Lima, Davi Alvarenga, et al.
Publicado: (2023)

The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi
por: Horta, Aline Luciano, et al.
Publicado: (2018)

Molecular characterization of the hexose transporter gene in benznidazole resistant and susceptible populations of Trypanosoma cruzi
por: dos Santos, Paula F, et al.
Publicado: (2012)

Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice
por: Gonzaga, Beatriz Matheus Souza, et al.
Publicado: (2022)

Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection
por: Li, Xiaomo, et al.
Publicado: (2021)

Bioactivity of the Ethanol Extract of Clove (Syzygium aromaticum) as Antitoxin
por: Afrendi, Erwin, et al.
Publicado: (2023)

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
por: Aguilera, Elena, et al.
Publicado: (2018)

Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole
por: Téllez, Jair, et al.
Publicado: (2019)

Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert()
por: Campos, Mônica C.O., et al.
Publicado: (2014)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2022)

Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells
por: Barbosa, Juliana Magalhães Chaves, et al.
Publicado: (2022)

Inhibitory activity of Syzygium aromaticum and Cymbopogon citratus (DC.) Stapf. essential oils against Listeria monocytogenes inoculated in bovine ground meat
por: de Oliveira, Thales Leandro Coutinho, et al.
Publicado: (2013)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
por: Assíria Fontes Martins, Tassiane, et al.
Publicado: (2015)

Anti-cholinesterase activity of the standardized extract of Syzygium aromaticum L.
por: Dalai, Manoj K., et al.
Publicado: (2014)

Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations
por: Moreira, Douglas de Souza, et al.
Publicado: (2018)

A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
por: Zingales, Bianca, et al.
Publicado: (2015)

Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi
por: Puente, Vanesa, et al.
Publicado: (2018)

The Potential Regressive Role of Syzygium aromaticum on the Reproduction of Male Golden Hamsters
por: Choi, Donchan, et al.
Publicado: (2014)

The clove (Syzygium aromaticum) genome provides insights into the eugenol biosynthesis pathway
por: Ouadi, Sonia, et al.
Publicado: (2022)

Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion
por: Shehabeldine, Amr M., et al.
Publicado: (2023)

Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection
por: Barbosa, Juliana Magalhães Chaves, et al.
Publicado: (2022)

Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2018)

Antiparasitic Activity of Hippeastrum Species and Synergistic Interaction between Montanine and Benznidazole against Trypanosoma cruzi
por: Piñeiro, Mauricio, et al.
Publicado: (2023)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display
por: Rodriguez Carnero, Luis Antonio, et al.
Publicado: (2023)

Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma
por: Kubatka, Peter, et al.
Publicado: (2017)

Chemical composition, in-vitro antibacterial and antioxidant activities of Syzygium aromaticum essential oil
por: Selles, Sidi Mohammed Ammar, et al.
Publicado: (2020)

In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis
por: Yassin, Mohamed Taha, et al.
Publicado: (2020)

A Quinoxaline Derivative as a Potent Chemotherapeutic Agent, Alone or in Combination with Benznidazole, against Trypanosoma cruzi
por: Rodrigues, Jean Henrique da Silva, et al.
Publicado: (2014)

Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection
por: Gatto, Mariana, et al.
Publicado: (2017)

The Ameliorative Effect of Zingiber officinale in Diabetic Nephropathy
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2014)

Aqueous Extract of Dried Flower Buds of Syzygium aromaticum Inhibits Inflammation and Oxidative Stress
por: Ahmad, Tasleem, et al.
Publicado: (2012)

Reproductive effects of lipid soluble components of Syzygium aromaticum flower bud in male mice
por: Mishra, Raghav Kumar, et al.
Publicado: (2013)

Semisynthesis of Derivatives of Oleanolic Acid from Syzygium aromaticum and Their Antinociceptive and Anti-Inflammatory Properties
por: Rali, Sibusiso, et al.
Publicado: (2016)

Evaluation of Therapeutic Potential of Eugenol-A Natural Derivative of Syzygium aromaticum on Cervical Cancer
por: Das, Arunava, et al.
Publicado: (2018)

In Vitro Antiviral Potential, Antioxidant, and Chemical Composition of Clove (Syzygium aromaticum) Essential Oil
por: Kiki, Manal Jameel
Publicado: (2023)

Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
por: Mejia, Ana Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_drusjtk5edhoab3g43ji8v097o